Extract from the Register of European Patents

EP Citations: EP4262754

Cited inInternational search
Type:Patent literature
Publication No.:WO2020102369  [XAI]
 (REGENXBIO INC et al.)
Type:Patent literature
Publication No.:WO2021071835  [XPA]
 (REGENXBIO INC et al.)
Type:Non-patent literature
Publication information:[A]   WRIGHT J FRASER ET AL: "Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector", CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT, CURRENT DRUGS, LONDON, GB, vol. 6, no. 2, 1 March 2003 (2003-03-01), pages 174 - 178, XP009092903, ISSN: 1367-6733
Type:Non-patent literature
Publication information:[A]   GNATENKO D V ET AL: "EXPRESSION OF THERAPEUTIC LEVELS OF FACTOR VIII IN HEMOPHILIA A MICE USING A NOVEL ADENO/ADENO-ASSOCIATED HYBRID VIRUS", THROMBOSIS AND HAEMOSTASIS, SCHATTAUER GMBH, DE, vol. 92, no. 2, 1 August 2004 (2004-08-01), pages 317 - 327, XP009036414, ISSN: 0340-6245
Cited inby applicant
Type:Patent literature
Publication No.:WO2017074526  
Type:Patent literature
Publication No.:WO2020028830  
Type:Patent literature
Publication No.:US2020246486  
Type:Non-patent literature
Publication information:  WRIGHT ET AL., MOLECULAR THERAPY, vol. 12, no. 1, 2005, pages 171 - 8
Type:Non-patent literature
Publication information:  CROYLE ET AL., GENE THERAPY, vol. 8, 2001, pages 1281 - 90
Type:Non-patent literature
Publication information:  TURNBULL ET AL., HUM GENE THER, vol. 11, no. 4, 2000, pages 629 - 35
Type:Non-patent literature
Publication information:  COTMORE ET AL., J VIROL, vol. 84, no. 4, 2010, pages 1945 - 56
Type:Non-patent literature
Publication information:  BALAJI ET AL., J SURG RES, vol. 184, no. 1, 2013, pages 691 - 8
Type:Non-patent literature
Publication information:  HAUCK ET AL., MOL THER, vol. 7, no. 3, 2003, pages 419 - 25